Gapping down
In reaction to disappointing earnings/guidance:
- ZTO -7.5%, HUYA -7%, YY -6.5%, BOOT -5.3%, TTWO -4%, BBY -3.1%, CPRT -1.9%, NDSN -0.8%, HRL -0.7%
Other news:
- SCPH -16.9% (prices offering of 5,780,347 shares of its common stock at $8.65 per share)
- RUTH -10.1% (announces that Jefferies will purchase $43.5 mln of stock)
- GLPG -5.7% (GILD and GLPG announce "positive" top-line results from Phase 2b/3 trial of filgotinib)
- FLXN -5.7% (prices underwritten public offering of 9,230,770 shares of its common stock at a price to the public of $9.75 per share)
- KDP -3.6% (40 mln share stock offering, or 2.8% of outstanding shares, by Maple Holdings)
- FIVN -3.5% (commences $650 mln private placement of convertible senior notes due 2025)
- BSX -3.2% (announces concurrent $750 mln common and preferred offerings)
- CSGP -2% (upsizes and prices its offering of 2,290,076 shares of its common stock at a price of $655.00)
- AVTR -1.5% (prices secondary offering of 45 mln shares of common stock at 16.25 per share)
- FSLY -1.2% (prices follow-on offering of 6 mln shares of common stock at $41.50 per share)
- NOV -0.7% (suspends quarterly dividend until further notice)
Analyst comments:
- IGT -3.5% (downgraded to Hold from Buy at Societe Generale)
- SQ -2.4% (downgraded to Sell from Neutral at UBS)
- MGM -2.3% (downgraded to Underperform from Neutral at BofA/Merrill; downgraded to Hold from Buy at Jefferies)
- LOGI -1.9% (downgraded to Neutral from Overweight at JP Morgan)
- SCHW -1.4% (downgraded to Neutral from Buy at BofA/Merrill)